Life Sciences and Healthcare

Life sciences companies face an increasingly complex and competitive landscape. To succeed in this environment, industry leaders and start-ups and their investors and capital providers need a strong partner that can provide creative yet practical legal and business solutions to help them navigate the unpredictable market. We can help.

Client Successes

  • Successfully defended Eli Lilly against patent infringement allegations by Sanofi involving medical device and formulation patents relating to Sanofi’s largest selling insulin

  • Serve as lead counsel to a global pharmaceutical company across four continents in high-profile government investigations and internal reviews

  • Advised Merck & Co. on major cross-border M&A transactions including its strategic agreement with Quartet Medicine, acquisition of Afferent Pharmaceuticals, and acquisition of therapeutics pioneer Rigontec

  • Represented Deerfield Management in the launch of a first-of-its-kind research partnership with the Broad Institute of MIT and Harvard, aimed at solving complex, early-stage therapeutic challenges related to serious unmet medical needs

  • Represented the lead arrangers in a US$900M bank financing for Bain Capital Private Equity's and J.H. Whitney Capital Partners' acquisition of Epic Health Services and PSA Healthcare

  • Life Sciences Practice Group of the Year

    Law 360
  • 50+

    Handled Investigations and compliance matters for life science clients in 50+ countries around the world
  • First ever successful defense of a pharmaceutical patent in an IPR

    First ever successful defense of a pharmaceutical patent in an IPR

Tackling Industry Challenges with Core Competencies

We bring a global, interdisciplinary approach to support our life sciences and healthcare clients’ multifaceted needs – from providing strategic counsel with respect to critical intellectual property, to navigating compliance, investigations, and enforcement issues, to structuring transactions and financing arrangements, to developing first-of-its-kind innovative strategic partnerships and licensing arrangements, to advising on unique data governance issues, IoT development and roll-out, and proactive privacy/cybersecurity assessments.

We partner with clients to understand and advise on their business and legal objectives, delivering tailored solutions, creative strategies, innovative value-add offerings, and seamless service across practices and regions. Our lawyers handle complex transactional, regulatory, and litigation matters, providing guidance and insight into the industry as a whole. The diversity of our cumulative experience allows us to be lean and targeted in our support.

  • Named 2019 Life Sciences IP Litigation Firm of the Year

    Managing IP

Premiere Client Portfolio, Successful Track Record, and Deep Industry Experience

Global life sciences companies face various challenges, from protecting patents to ensuring compliance to building a strong product pipeline. Whether you’re a pharma giant or an innovative start-up, how can you best manage your resources—and your risks—in pursuit of growth?

We help our clients protect and enhance their value in this complex, unpredictable marketplace:

  • Partnering with more than half of the top 50 life sciences companies by market capitalization

  • Handling numerous high-stakes, bet-the-company patent litigations, and post-grant proceedings

  • Advising on high-profile government compliance, investigations, and enforcement issues, including FDA regulatory and enforcement advice

  • Structuring complex cross-border transactions—from M&A to innovative strategic partnerships to licensing and funding arrangements

  • Developing and implementing compliance risk management programs in collaboration with our Life Sciences Consulting Group

  • Nearly every lawyer in our premier IP practice has a technical degree in life sciences, engineering, or chemistry. The group includes PhD-level scientific advisors who have substantial experience in pharmaceutical patent litigation.

  • Named MVPs in IP Technology, Life Sciences and Appellate


Recognition for Our Practice

  • Named IPR Team of the Year by LMG Life Sciences.

  • Ranked by Managing Intellectual Property’s IP Stars as Tier 1 in Life Sciences.

  • The firm was named Life Sciences Litigation Firm of the Year by

    Managing Intellectual Property.

  • The firm is ranked Gold in New York by 2019 IAM Patent 1000, noting the firm’s strength in Life Sciences.

  • The firm was shortlisted by Benchmark Litigation for "California - Intellectual Property Litigation Firm of the Year"

  • Recognized as Life Sciences Practice Group of the Year by Law360.

  • Recognized as Most Valuable Players – Life Sciences and IP by Law360.

  • Ranked in consecutive editions of Global Investigations Review 

    GIR 100, for handling sophisticated cross-border government-led and internal investigations.

  • Recognized as a top firm for Healthcare: Life Sciences, Legal 500 U.S.

  • "The team is known as an international firm with a strong U.S. footprint and sector expertise in life sciences and frequently called upon for strategically significant cross-border transactions."

    Chambers USA

Contact Us

Image: Gary F. Giampetruzzi
Gary F. Giampetruzzi

Life Sciences Practice Group Chair

Image: S. Joy Dowdle
S. Joy Dowdle

Life Sciences Practice Group Vice Chair

Image: BJ D'Avella
BJ D'Avella

Life Sciences Consulting Group Leader

About the Life Sciences Consulting Group Right Hand Side

Nehmen Sie Kontakt mit uns auf

Kontaktiere uns